News - Curant Rare

News

Press Releases

Curant Rare and IntraBio Bring Real-World Evidence to Niemann-Pick Disease Type C Care

Curant Rare and IntraBio Bring Real-World Evidence to Niemann-Pick Disease Type C Care

Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products

Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products

Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics

Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics

Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™, the First and Only FDA-Approved Oral Maintenance Therapy Shown to Cut the Risk of High-Risk Neuroblastoma Relapse in Half

Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™, the First and Only FDA-Approved Oral Maintenance Therapy Shown to Cut the Risk of High-Risk Neuroblastoma Relapse in Half

Curant Health Launches Curant Rare™, A Specialized Division Dedicated to Rare & Orphan Disease Care

Curant Health Launches Curant Rare™, A Specialized Division Dedicated to Rare & Orphan Disease Care

Curant Health Selected By IntraBio as the Exclusive Specialty Pharmacy for AQNEURSA™ (levacetylleucine), the First Stand-Alone Therapy for Niemann-Pick Disease Type C

Curant Health Selected By IntraBio as the Exclusive Specialty Pharmacy for AQNEURSA™ (levacetylleucine), the First Stand-Alone Therapy for Niemann-Pick Disease Type C

Insights

The Growing Importance of Evidence in Rare Disease

The Growing Importance of Evidence in Rare Disease

Aug 31, 2026 | Real World Evidence

Quick Links

Home

About Us

Contact

News

Terms & Conditions

Privacy Policy

Projects

Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics

Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™